Edward G. Carr's most recent trade in Dianthus Therapeutics Inc was a trade of 60,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dianthus Therapeutics Inc | Edward G. Carr | CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Dianthus Therapeutics Inc | Edward G. Carr | CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Dianthus Therapeutics Inc | Edward G. Carr | CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Abeona Therapeutics Inc | Edward G. Carr | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 476,000 | 476,000 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Edward G. Carr | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 238,000 | 429,291 (0%) | 0% | 0 | Common stock | |
| Abeona Therapeutics Inc | Edward G. Carr | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 1.80 per share. | 31 Mar 2021 | 35,000 | 191,291 (0%) | 0% | 1.8 | 62,846 | Common stock |
| Abeona Therapeutics Inc | Edward G. Carr | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 1.85 per share. | 31 Mar 2021 | 20,445 | 226,291 (0%) | 0% | 1.9 | 37,866 | Common stock |
| Abeona Therapeutics Inc | Edward G. Carr | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Edward G. Carr | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 50,000 | 246,736 (0%) | 0% | 0 | Common stock | |
| Abeona Therapeutics Inc | Edward G. Carr | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 51,081 | 51,081 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Edward G. Carr | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Nov 2020 | 51,081 | 0 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Edward G. Carr | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Edward G. Carr | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Nov 2020 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Edward G. Carr | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 28,919 | 28,919 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Edward G. Carr | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Nov 2020 | 28,919 | 0 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Edward G. Carr | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Edward G. Carr | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Nov 2020 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Edward G. Carr | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2020 | 143,182 | 196,736 (0%) | 0% | 0 | Common Stock |